A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation

ConclusionCompared with AADs, RFCA significantly improves clinical outcomes and QALYs among patients with paroxysmal or persistent AF. From the Chinese payer ’s perspective, RFCA is a cost-effective therapy over long-term horizons.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research